Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-14

Clinical Trial Update: NeuWave Microwave Ablation HCC China Study [NA]

View source ↗

Summary

Completed clinical trial evaluating NeuWave Microwave Ablation for hepatocellular carcinoma in China; results were posted on 2025-02-14.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • NeuWave Microwave Ablation

Snippet

Sponsor: Ethicon, Inc. | Conditions: Liver Tumor, Hepatocellular Carcinoma | NA | Status: COMPLETED | Results posted: 2025-02-14